Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Goodman

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
The American Journal of Psychiatry|February 1, 1994
Physical symptoms associated with paroxetine discontinuationL C Barr, W K Goodman, L H Price
Pharmacopsychiatry|May 1, 1993
The pharmacotherapy of obsessive-compulsive disorderC J McDougle, W K Goodman, L H Price
International Clinical Psychopharmacology|June 1, 1992
The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorderW K Goodman, C J McDougle, L H Price
The Journal of Clinical Psychiatry|January 1, 1997
Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditionsW K Goodman, H Ward, A Kablinger, et al.
Journal of Autism and Developmental Disorders|December 1, 1990
Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case reportC J McDougle, L H Price, W K Goodman
The Journal of Clinical Psychiatry|April 1, 1992
Pharmacotherapy of obsessive compulsive disorderW K Goodman, C J McDougle, L H Price
The American Journal of Psychiatry|October 1, 1992
Acute exacerbation of body dysmorphic disorder during tryptophan depletionL C Barr, W K Goodman, L H Price
Depression and Anxiety|August 17, 2000
Stability of subclinical obsessive compulsive disorder in college studentsM R Morris, S Forbes, M M Bradley, et al.
Current Psychiatry Reports|July 27, 2001
The psychobiology of obsessive-compulsive disorder: how important is the role of disgust?D J Stein, Y Liu, N A Shapira, et al.
International Clinical Psychopharmacology|March 1, 1996
Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trialW K Goodman, M J Kozak, M Liebowitz, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
The American Journal of Psychiatry|February 1, 1994
Physical symptoms associated with paroxetine discontinuationL C Barr, W K Goodman, L H Price
Pharmacopsychiatry|May 1, 1993
The pharmacotherapy of obsessive-compulsive disorderC J McDougle, W K Goodman, L H Price
International Clinical Psychopharmacology|June 1, 1992
The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorderW K Goodman, C J McDougle, L H Price
The Journal of Clinical Psychiatry|January 1, 1997
Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditionsW K Goodman, H Ward, A Kablinger, et al.
Journal of Autism and Developmental Disorders|December 1, 1990
Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case reportC J McDougle, L H Price, W K Goodman
The Journal of Clinical Psychiatry|April 1, 1992
Pharmacotherapy of obsessive compulsive disorderW K Goodman, C J McDougle, L H Price
The American Journal of Psychiatry|October 1, 1992
Acute exacerbation of body dysmorphic disorder during tryptophan depletionL C Barr, W K Goodman, L H Price
Depression and Anxiety|August 17, 2000
Stability of subclinical obsessive compulsive disorder in college studentsM R Morris, S Forbes, M M Bradley, et al.
Current Psychiatry Reports|July 27, 2001
The psychobiology of obsessive-compulsive disorder: how important is the role of disgust?D J Stein, Y Liu, N A Shapira, et al.
International Clinical Psychopharmacology|March 1, 1996
Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trialW K Goodman, M J Kozak, M Liebowitz, et al.
Pageof 10